I reviewed your homepage, Services and About pages and your public profile to understand how Surecell presents itself. You have built real clinical reputation and reach: 102 Google reviews at 4.1, a national telehealth offering from Melbourne and a professional network reflected in 262 referring domains and 1,177 backlinks. That credibility is not being surfaced clearly where premium patients and clinician referrers decide, so high-ticket PRP, XCell and allied referrals are being lost to competitors with clearer clinical proof.
Your online reputation
4.1
Google star rating
102
Verified reviews
High
Reputation strength
Google Business Profile
Your online presence — what the data reveals
AI Visibility
Low
Authority Score
11
out of 100
Organic traffic
2656
est. monthly visits
Traffic Trend
-8
%
past 12 months
Organic Keywords
1011
ranking terms
Keyword Trend
+19
%
past 12 months
Backlinks
1177
total
Paid traffic
0
0 paid campaigns
Digital maturity
Level 2
out of 5
You have a visible patient reputation: 102 Google reviews at an average 4.1, which signals consistent patient volume and satisfaction. You also have a strong professional footprint online with 262 referring domains and 1,177 backlinks that would be hard for a new clinic to match. If the site is reworked to put those assets front and centre, that reputation and network can be converted into more bookings and clinician referrals for high-value regenerative treatments.
How your website scores
TECH STACK
UX OBSERVATIONS
Service breadth is visible but not prioritised — presenting every offering with equal weight dilutes the clinic's specialist PRP/cell therapy positioning and reduces predictable referral and booking flow for high‑value treatments.
Basic trust elements (address, phone, hours) are present but not carrying authority — absence of clinician credentials, patient outcomes, research or strong social proof is reducing professional referral confidence.
Hierarchy and CTAs are weak — a non-dominant 'Book an Appointment' element and many same‑weight tiles fail to structure decision‑making, creating friction and lowering conversion for interstate or premium patients.
With roughly 2,657 monthly visits and a Semrush visibility flagged as Low, most interested visitors never see clear clinical proof and do not convert online. Coupled with a UX conversion score of 2, people looking for advanced therapies are likely to call or go to competitors instead. Your 102 reviews and 262 referring domains show demand and credibility, but because that proof is not presented where clinicians and premium patients look, you are losing high-value appointments and downstream referrals.
The three gaps holding you back
What's possible when these gaps are closed
Make Surecell the obvious specialist for PRP, XCell and hyperbaric therapy so visitors recognise your clinical focus immediately. By placing clinical teams, outcomes and pathways front and centre, you can turn a share of the current 2,657 monthly visitors into qualified bookings. Use the 102 Google reviews and 262 referring domains as visible proof to support premium pricing and stronger clinician relationships.
Design booking flows scoped specifically for PRP and XCell so patients can book the right consultation without phoning first. A modest uplift from the current UX conversion score of 2 could capture a measurable portion of the 2,657 monthly visitors and materially increase high-ticket bookings. That change will also make clinician referrals easier to action and track.
Surface case studies, clinician endorsements and outcome data in the places referrers and decision makers look so those 262 referring domains and 1,177 backlinks turn into active referral channels. That will use your 102 reviews and existing network to lift authority from an 11 score and improve organic visibility beyond the current national rank of 73,353. Better targeted evidence will make telehealth and interstate referrals a dependable pipeline for premium treatments.
This report was prepared by Redfox Digital using publicly available SEO, UX and reputation data.
